People with metabolic syndrome who try intermittent fasting see a small but real drop in their total cholesterol levels after a few months.
Scientific Claim
Intermittent fasting reduces total cholesterol by 0.32 mmol/L in adults with metabolic syndrome over interventions averaging 3 months, indicating a modest improvement in lipid profile.
Original Statement
“total cholesterol level reduced by 0.32 mmol/L (95% CIs: −0.60; −0.05)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The effect is statistically significant and derived from RCTs. The claim accurately reflects the reported effect size and confidence interval.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting lowered their total cholesterol by exactly 0.32 mmol/L, which matches the claim — so yes, it supports it.